Cargando…

P1253: MAVORIXAFOR DISRUPTS THE CROSS TALK BETWEEN WALDENSTRÖM’S MACROGLOBULINEMIA CELLS AND THE BONE MARROW MICROENVIRONMENT RESULTING IN ENHANCED SENSITIVITY TO B-CELL TARGETED THERAPIES

Detalles Bibliográficos
Autores principales:	Monticelli, H., Kruitwagen, T., Tardelli, M., Rebelo, T., Maierhofer, B., Maier-Munsa, S., Zmajkovicova, K., Taveras, A. G., Nguyen, C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Posters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430520/ http://dx.doi.org/10.1097/01.HS9.0000847876.35483.fd

Ejemplares similares

P793: SCREENING OF NATURALLY OCCURRING CXCR4 VARIANTS FOR IDENTIFICATION OF NOVEL PATHOGENIC MUTATIONS FOR WHIM SYNDROME
por: Pawar, S., et al.
Publicado: (2022)

Genotype–phenotype correlations in WHIM syndrome: a systematic characterization of CXCR4(WHIM) variants
por: Zmajkovicova, Katarina, et al.
Publicado: (2022)

Pseudohyperphosphatemia in Waldenstrom's Macroglobulinemia
por: Amalnath, S. D., et al.
Publicado: (2013)

Waldenstrom’s Macroglobulinemia: An Update
por: Mazzucchelli, Maddalena, et al.
Publicado: (2018)

P792: CRISPR/CAS9-BASED MODEL OF HETEROZYGOUS CXCR4 WT/R334X MUTATION TO STUDY CELLULAR PHENOTYPES IN WHIM SYNDROME
por: Zmajkovicova, K., et al.
Publicado: (2022)

Diagnostics in Waldenström’s macroglobulinemia: a consensus statement of the European Consortium for Waldenström’s Macroglobulinemia
por: Dogliotti, Irene, et al.
Publicado: (2022)

Single-cell profiles reveal tumor cell heterogeneity and immunosuppressive microenvironment in Waldenström macroglobulinemia
por: Sun, Hao, et al.
Publicado: (2022)

Waldenstrom's macroglobulinemia associated with eosinophilia
por: You, Eunkyoung, et al.
Publicado: (2013)

How to manage Waldenstrom's macroglobulinemia
por: Buske, C, et al.
Publicado: (2013)

Waldenstrom macroglobulinemia: prognosis and management
por: Oza, A, et al.
Publicado: (2016)

Waldenstrom macroglobulinemia: prognosis and management
por: Oza, A, et al.
Publicado: (2015)

Cutaneous macroglobulinosis with Waldenström macroglobulinemia
por: Hassab-El-Naby, Hussein M.M., et al.
Publicado: (2020)

Genomic landscape of Waldenström's macroglobulinemia
por: Treon, Steven P., et al.
Publicado: (2019)

Bone localization of Waldenstrom’s macroglobulinemia
por: Daste, Camille, et al.
Publicado: (2023)

Clinical, Laboratory, and Bone Marrow Findings of 31 Patients With Waldenström Macroglobulinemia
por: Ahn, Ari, et al.
Publicado: (2020)

Pseudovitelliform Subfoveal Deposit in Waldenström's Macroglobulinemia
por: Brolly, Aurélie, et al.
Publicado: (2012)

Splenic re-irradiation for waldenstrőm’s macroglobulinemia
por: Wei, Zhou, et al.
Publicado: (2012)

Membranoproliferative glomerulonephritis complicating Waldenström’s macroglobulinemia
por: Kratochvil, David, et al.
Publicado: (2012)

Clinical Features of Waldenstrom Macroglobulinemia in Korea
por: Bang, Soo-Mee, et al.
Publicado: (2004)

CNS Vasculitis Associated with Waldenström Macroglobulinemia
por: Riangwiwat, Tanawan, et al.
Publicado: (2016)

Waldenström macroglobulinemia treatment algorithm 2018
por: Gertz, Morie A.
Publicado: (2018)

Stiff-person Syndrome with Waldenström Macroglobulinemia
por: Horiuchi, Kazuhiro, et al.
Publicado: (2018)

Waldenström macroglobulinemia: biology, genetics, and therapy
por: Paludo, Jonas, et al.
Publicado: (2016)

New developments in the management of Waldenström macroglobulinemia
por: Abeykoon, Jithma P, et al.
Publicado: (2017)

Waldenstrom's Macroglobulinemia: A case report
por: Kolikkat, Nejima, et al.
Publicado: (2020)

Focal Segmental Glomerulosclerosis in Waldenström's Macroglobulinemia
por: Batra, Akshee, et al.
Publicado: (2020)

Chylothorax as an Initial Manifestation of Waldenström macroglobulinemia
por: Rodriguez Botero, Natalia, et al.
Publicado: (2020)

Venetoclax in Previously Treated Waldenström Macroglobulinemia
por: Castillo, Jorge J., et al.
Publicado: (2022)

Waldenström's macroglobulinemia front line treatment
por: Tedeschi, Alessandra, et al.
Publicado: (2019)

Treatment options for relapsed Waldenström's Macroglobulinemia
por: Grunenberg, Alexander, et al.
Publicado: (2019)

Managing Waldenström’s macroglobulinemia with BTK inhibitors
por: Buske, Christian, et al.
Publicado: (2022)

HPV+ Oropharyngeal Cancer in Waldenström Macroglobulinemia
por: Raslan, Shahm, et al.
Publicado: (2023)

A Diagnostic Dilemma: Waldenström's Macroglobulinemia/Plasma Cell Leukemia
por: Sethi, Bhawna, et al.
Publicado: (2012)

Mast cell density and its clinical relevance in Waldenström's macroglobulinemia
por: Lemal, Richard, et al.
Publicado: (2022)

Waldenstrom macroglobulinemia involving the superior rectus muscle
por: Hellman, J.B., et al.
Publicado: (2018)

Localized retinal degeneration secondary to Waldenström's macroglobulinemia
por: Ratra, Dhanashree, et al.
Publicado: (2017)

Intensely Pruritic Papules and Plaques in Waldenstrom's Macroglobulinemia
por: Lee, Solam, et al.
Publicado: (2018)

Evaluating ibrutinib in the treatment of symptomatic Waldenstrom’s macroglobulinemia
por: Papanota, Aristea-Maria, et al.
Publicado: (2019)

Correction: Waldenström macroglobulinemia treatment algorithm 2018
por: Gertz, Morie A.
Publicado: (2019)

Cutaneous amyloidosis as the first presentation of Waldenstrom macroglobulinemia
por: Rafiei, Rana, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_but28ve5rek6opv3rsthb1qm0q